Istios Health Expands to Nephrology, Forging a New Path for Specialty Care

PHOENIX, AZ – February 19, 2026

Physician-enablement company Istios Health announced today a significant expansion into nephrology, forging partnerships with three independent practices in the Northeast. The move signals a strategic push to apply its integrated care-and-research model, already established in infectious disease, to the growing challenge of chronic kidney disease.

The new partners—Coordinated Kidney Care Group and Teredesai McCann & Associates in Pennsylvania, and Central Mass Nephrology in Massachusetts—will join the Istios network, gaining access to a sophisticated platform that merges virtual care with clinical research capabilities. This expansion extends the Phoenix-based company's infrastructure into renal care, aiming to reshape how specialty medicine is delivered and how new treatments are discovered.

A Hybrid Model for Modern Medicine

At the heart of the expansion is Istios Health's proprietary Istios Navigator™ platform, an "operating system" designed to break down the traditional silos between patient care and clinical research. The platform integrates tele-specialty services, standardized clinical workflows, and structured data capture directly into the daily operations of a specialty practice.

This technology-driven approach allows physicians to conduct inpatient consults, manage outpatient care through virtual visits, and oversee long-term disease management within a single, unified environment. Crucially, the same system enables these practices to participate in clinical trials and real-world evidence (RWE) initiatives without the need for separate, often cumbersome, research infrastructure.

“Historically, specialty care delivery and clinical research have operated in parallel systems,” said Nikos Nikolopoulos, Co-Founder and CEO of Istios Health, in a statement. “By integrating virtual specialty care, clinical research, and RWE inside everyday clinical practice, we improve access for patients while strengthening recruitment, retention, and longitudinal outcomes understanding for sponsors.”

The model is designed for cognitive specialties like nephrology and infectious disease, which are centered on diagnosis and longitudinal management rather than procedures. While many patient encounters can be handled virtually, the partner practices maintain their physical clinics. This hybrid network ensures patients can still receive necessary in-person evaluations, lab monitoring, or infusion therapies, creating a flexible and patient-centric system.

Empowering Independence Amidst Consolidation

For independent medical practices, the current healthcare landscape presents a formidable challenge. Faced with rising administrative burdens, the high cost of technology, and intense competition from large hospital systems and private equity-backed groups, many are forced to consider acquisition. Istios Health’s physician-enablement model offers a compelling alternative.

Partner practices remain independently owned and physician-led, preserving their clinical autonomy. They leverage Istios Health's shared infrastructure for virtual care deployment, research operations support, and data management. This allows them to benefit from the scale and resources of a larger network without sacrificing the independence that often defines their practice culture and patient relationships.

The leaders of the new partner practices highlighted this balance of independence and enhanced capability. “Partnering with Istios allows us to expand nephrology access while maintaining our commitment to high-quality patient care,” said Dr. Ross Betts of Coordinated Kidney Care Group.

This sentiment was echoed by Dr. Matt Pesacreta of Teredesai McCann & Associates, who noted, “This collaboration strengthens our ability to support hospitals and manage patients longitudinally while contributing to clinical advancement.”

By providing the technological and operational backbone, the model enables smaller groups to compete effectively and thrive. It addresses physician burnout by reducing administrative tasks and allows practices to focus on high-value clinical work and innovative research, making them more attractive to both patients and top medical talent. Dr. Ashish Verma of Central Mass Nephrology emphasized the dual benefit, stating, “Integrating research into routine care benefits both patients and innovation.”

Tackling the Chronic Kidney Disease Crisis

The expansion into nephrology is particularly timely. Chronic kidney disease (CKD) represents a silent and growing public health crisis in the United States, affecting an estimated 37 million adults, or 1 in 7. The vast majority are unaware they have the condition, leading to late diagnoses and more severe outcomes.

Istios Health’s model directly addresses several key challenges in kidney care. By incorporating telehealth, it can dramatically improve access to specialists for patients in rural and underserved communities, who often face long travel times and appointment delays. This enhanced access can lead to earlier diagnosis, more consistent management of contributing factors like hypertension and diabetes, and ultimately, a slower progression of the disease.

Furthermore, integrating clinical research into community-based nephrology practices has profound implications. Historically, clinical trials have been concentrated in major academic medical centers, limiting participation and often failing to recruit patient populations that reflect the real-world diversity of the disease.

By transforming its partner practices into a nationwide research network, Istios decentralizes the discovery process. This makes it easier for patients to participate in cutting-edge trials with their trusted local physician, reducing logistical burdens and potentially increasing trial enrollment and retention. This approach not only accelerates the development of new therapies but also helps ensure they are tested on a more representative patient base.

The platform’s RWE technology layer continuously captures longitudinal clinical data across all care settings. This structured data collection, running parallel to routine care, enables ongoing outcome tracking, monitoring of treatment adherence, and powerful observational research. This combination of traditional clinical trials and robust real-world evidence generation creates a continuous loop where everyday patient care informs and accelerates medical discovery.

Istios Health has indicated that this move is just the beginning. The company plans to continue expanding its nephrology footprint into additional markets throughout 2026, as it pursues a broader multi-specialty strategy built on this innovative, integrated foundation.